Jaime Ariel Isern

Dr. Jaime Ariel Isern

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JIJaime Ariel Isern
Jaime Ariel Isern
RCRenzo Carlucci
Renzo Carlucci
GLGuillermo Roberto Labadie
Guillermo Roberto Labadie
Exequiel O. J. PortaExequiel O. J. Porta
Exequiel O. J. Porta
Parasitic diseases represent a severe global burden, with current treatments often limited by toxicity, drug resistance, and suboptimal efficacy in chronic infections. This review examines the emerging role of triazole-based compounds, originally developed as antifungals, in advanced antiparasitic therapy. Their unique structural properties, particularly those of 1,2,3- and 1,2,4-triazole isomers, facilitate diverse binding interactions and favorable pharmacokinetics. By leveraging innovative synthetic approaches, such as click chemistry (copper-catalyzed azide–alkyne cycloaddition) and structure-based design, researchers have repurposed and optimized triazole scaffolds to target essential parasite pathways, including sterol biosynthesis via CYP51 and other novel enzymatic routes. Preclinical studies in models of Chagas disease, leishmaniasis, malaria, and helminth infections demonstrate that derivatives like posaconazole, ravuconazole, and DSM265 exhibit potent in vitro and in vivo activity, although their primarily static effects have limited their success as monotherapies in chronic cases. Combination strategies and hybrid molecules have demonstrated the potential to enhance efficacy and mitigate drug resistance. Despite challenges in achieving complete parasite clearance and managing potential toxicity, interdisciplinary efforts across medicinal chemistry, parasitology, and clinical research highlight the significant potential of triazoles as components of next-generation, patient-friendly antiparasitic regimens. These findings support the further optimization and clinical evaluation of triazole-based agents to improve treatments for neglected parasitic diseases.

14 May 2025 in ChemBioChem
Verified
Journal Article
Open access
JIJaime Ariel Isern
Jaime Ariel Isern
Exequiel O. J. PortaExequiel O. J. Porta
Exequiel O. J. Porta
KKKarunakaran Kalesh
Karunakaran Kalesh
ZKZisis Koutsogiannis
Zisis Koutsogiannis
DCDavide Cazzola
Davide Cazzola
PSPatrick Steel
Patrick Steel
Leishmaniasis, a vector‐borne neglected tropical disease, caused by the protozoan parasite Leishmania , is a major global public health challenge with millions of new cases annually. Treatment of leishmaniasis is difficult for many reasons including multiple lifecycle stages, involving both an infective insect vector form, the promastigote, and a disease‐causing intracellular mammalian host form, the amastigote, and increasing drug tolerance that are all linked by the interplay between parasite and host. Activity‐based protein profiling (ABPP) was employed using new cell‐permeable fluorophosphonate probes to explore serine hydrolases (SHs) in Leishmania mexicana with subsequent analysis enabled by secondary reaction with an affinity reagent. Importantly, these cell‐permeable probes are capable of accessing all lifecycle stages including the disease‐critical intramacrophage amastigote. Probe efficacy is a combination of both target engagement and subsequent accessibility to the affinity agent. Fourteen SHs, including peptidases and lipases, were identified in the L. mexicana proteome with comparative profiling of different parasite life‐stages revealing significant changes in SH activity across the lifecycle stages. This intracellular ABPP approach provides insights into the host–parasite interactome demonstrating that SHs function as important virulence factors with Z‐Pro‐Prolinal, a known prolyl‐oligopeptidase inhibitor, being able to reduce parasite infectivity in the macrophage by altering multiple SH targets.

4 June 2026 in Nature Communications
Verified
Journal Article
Open access
ARAnnika Richter
Annika Richter
JIJaime Ariel Isern
Jaime Ariel Isern
MRMax Ruwolt
Max Ruwolt
SLSarah Lampe
Sarah Lampe
AMAbhirup Majumdar
Abhirup Majumdar
DFDorothea Fiedler
Dorothea Fiedler
Inositol polyphosphates (InsPs) and inositol pyrophosphates (PP-InsPs) are highly phosphorylated signaling molecules involved in diverse cellular processes. To resolve discrete signaling events mediated by these structurally related metabolites, a mass spectrometry–based approach was developed to derive apparent binding constants on a proteome-wide scale. The method employs chemically synthesized affinity reagents for inositol hexakisphosphate (InsP 6 ) and the inositol pyrophosphates 1PP-InsP 5 , 5PP-InsP 5 , and 1,5(PP) 2 -InsP 4 (InsP 8 ). Concentration-dependent affinity enrichment combined with tandem mass tag (TMT) labeling enabled identification and quantification of ligand–protein interactions for hundreds of proteins from mammalian cell lysates. Biochemical and functional validation of selected targets demonstrated engagement with endogenous ligands. Comparison of enrichment conditions revealed a strong dependence of PP-InsP binding on Mg 2+ ions. Additionally, gene ontology analysis linked PP-InsP interactors to nuclear and nucleolar RNA processing, and subsequent analyses could identify several pyrophosphorylation sites, previously uncharacterized. In summary, these datasets provide valuable resources for exploring PP-InsP–dependent signaling pathways across biological systems.

20 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JIJaime Ariel Isern
Jaime Ariel Isern
MMMaría Gabriela Mediavilla
María Gabriela Mediavilla
Exequiel O. J. PortaExequiel O. J. Porta
Exequiel O. J. Porta
MMMarcelo L. Merli
Marcelo L. Merli
MBMaría Sol Ballari
María Sol Ballari
PSPatrick Steel
Patrick Steel
Serine hydrolases (SHs) constitute one of the largest enzyme superfamilies in eukaryotes, yet their roles in Trypanosoma cruzi, the causative agent of Chagas disease, remain largely uncharacterized. Here, we report an activity-based chemoproteomic map of the T. cruzi epimastigote serinome by combining genome-informed in silico curation with whole-cell activity-based protein profiling (ABPP) using a panel of cell-permeable fluorophosphonate (FP)-alkyne probes. Whole-cell labelling followed by label-free quantitative proteomics (LFQ-MS), identified 37 enriched SH-like proteins, including 35 with conserved or partially conserved catalytic triad/dyad features, spanning lipases, peptidases, esterases, and previously uncharacterized hydrolases. The 35 SHs represent approximately 63 % of the 56 predicted SHs retained after catalytic-site curation. Domain architecture analysis revealed broad structural diversity, while orthologue-based localization data suggested association with multiple subcellular compartments, including glycosomal, mitochondrial, and endosomal localizations. Gene Ontology enrichment highlighted lipid metabolic and catabolic processes as dominant functional themes, and protein-protein interaction network analysis supported functional connectivity among the captured enzymes. Several identified SHs, including oligopeptidase B, prolyl oligopeptidase Tc80, serine carboxypeptidase CPB1, and phospholipase A1 (PLA1) have previously been characterized in trypanosomatids as virulence factors and as mediator of host-pathogen interactions. Together, these findings establish a fluorophosphonate-based chemoproteomic resource for the kinetoplastid community and prioritize probe-accessible active T. cruzi SHs for future functional validation and antiparasitic inhibitor discovery.